INTRODUCTION
Retinoic acid (RA) exerts striking effects on cell proliferation and differentiation (1) of several tissues including skin, cartilage and hematopoietic and nervous systems (1 -5) . To date, at least three classes of proteins that directly interact with retinoic acid have been identified. Two of these, the nuclear receptors for alltrans retinoic acid (RARs) (6) and retinoid X receptors (RXR) (7) , are members of the nuclear receptor superfamily of liganddependent transcription factors. While RA is the ligand for RAR, 9-cis retinoic acid is the specific ligand for RXR (8, 9) . The third class of proteins includes the cellular retinoic acid-binding proteins (CRABPs) (10) which are localized in the cytoplasm. Two types of CRABP have been identified and the corresponding human cDNAs have been cloned (11, 12) . Although the CRABPs bind retinoic acid with high specificity, their physiological role has not been conclusively defined. They may serve as an intracellular transport system for retinoic acid, or in controlling the rate of metabolism of retinoic acid. In either case, they may regulate the amount of retinoic acid available to interact with the receptors themselves.
Both CRABP-I and II are found in human skin (13) . However, CRABP-II, not CRABP-I, is specifically induced by RA both in cultured cells and in human skin (11) (12) (13) . These findings suggest that the induction of CRABP-II either in vitro or in vivo could be a good indicator for the clinical evaluation of RA treatment, as well as for the measurement of retinoid efficacy in pharmaceutical research.
The detection of specific RNA transcripts is widely used to monitor gene expression. Conventional methods of RNA analysis such as Northern blot hybridization followed by densitometric quantitation require 10-40 fig total RNA. However, studies with human samples are often limited by the small quantities of tissue obtained by needle aspiration or punch biopsy. Techniques such as in situ hybridization or immunohistochemistry are exquisitely sensitive and thus may be used with small samples, but it is difficult to obtain quantitative results using these methods. Therefore, a method combining both high sensitivity and reliable quantitation is needed.
The polymerase chain reaction (PCR) has been employed in several recent analyses of gene expression (14, 15) . However, these studies provided only relative comparisons of RNA levels since no internal standard of known concentration was used. Gilliland et. al. (16) developed a method in which a competitor DNA was used as an internal standard to quantitate the amount of cytokine mRNA in cultured cells. Competitor DNAs in this case consisted of a genomic fragment of the cytokine differing from the target cDNA by having a small intron. This method, however, does not provide a control for the efficiency of the reverse transcription reaction (RT). Several reports have described quantitative PCR amplification utilizing a housekeeping gene RNA, such as /3-actin, as an internal standard (17, 18) . Although this strategy controls for RT efficiency, the efficiencies of amplification of two unrelated cDNAs using two sets of primers are likely to be significantly different. Ideally, a quantitative PCR protocol should be: 1) sensitive, so that very little sample is required; 2) accurate, giving the absolute amount of RNA expressed; 3) rapid, with results obtained within hours rather than days; and 4) widely applicable. Here we report a quantitative PCR method in which the internal standard is a synthetic RNA generated by in vitro transcription from the cDNA of interest, with a small deletion in the coding region. We evaluated the method by quantitating human CRABP-II RNA in both cultured cells in vitro and human skin biopsies in vivo. We demonstrate that the quantitative PCR procedure developed satisfies all the criteria mentioned above and can be used for accurate quantitation of a specific RNA from small samples.
MATERIALS AND METHODS

Cell culture
Human skin fibroblast cells (ATCC CRL 1513) were cultured in the alpha-MEM medium with 10% fetal calf serum (Gibco). When confluent, medium was changed to alpha-MEM with 10% charcoal-stripped fetal calf serum and cells were treated with RA (10~6 M) dissolved in ethanol. After 24 hours of exposure to RA, cells were lysed for RNA preparation.
Internal standard RNA
The cDNA of human CRABP-II (a gift from DR. A. Astrom, the University of Michigan) was subcloned into the vector Bluescript SK~ (11) . The resulting construct was linearized with Xcm I which cuts at a unique site within the CRABP-II coding region and then digested with BAL 31 exonuclease for about 10 min at 30°C (1 /tg DNA/0.1 unit of BAL 31, BRL). The digested ends were blunted by Klenow and self-ligated. The new recombinant plasmids and the deletion were confirmed by DNA sequencing. A plasmid, named CRABP-D2, in which 42 bp had been deleted (corresponding to the cDNA sequence from 213 bp to 254 bp, 11), was picked as a template for in vitro transcription by T3 polymerase following the manufacturer's instruction (Promega). The resulting RNA was treated with RNase-free DNase RQ1 (Promega), passed through a Sephadex G50 spin column (19) , and purified on a low melting temperature agarose gel (19) . The RNA was quantitated spectrophotometrically at 260 ran, diluted to the concentration of 1 attomole//xl and stored at -70°C until needed.
Oligonucleotides
Two CRABP-n-specific oligonucleotides were used for the PCR amplification: 1) CRB-1, 5'-GGCAA CTGGA AAATC ATCCG ATCGG AAAAC; 2) CRB-2, 5'-CACTC TCCCA TTTCA CCAGG CTCTT ACAG. The oligonucleotide CRB-2 was also used as the primer for reverse transcription to generate the specific CRABP-H first strand cDNA.
RNA preparation and Northern blot analysis
Total RNA from cultured cells was prepared using the guanidium/cesium chloride method (20) . For in vivo RA and sodium lauryl sulfate (SLS) treatment, 0.1% Retin-A cream (Ortho Pharmaceuticals), cream base alone, or cream containing 2% SLS was applied for 16 hours as described (11) . The purification of total RNA from human skin was performed as described (11) . For Northern blots, 20 /ig samples of total RNA were denatured using glyoxal and DMSO, electrophoretically separated on a 1.1% agarose gel, and transferred to a Hybond-N + nylon membrane (Amersham). Following fixation in 50mM NaOH, blots were prehybridized in 25mM KPO 4 , pH 7.4/5 XSSC/5 XDenhardt's/50% formamide and 50 /tg/ml salmon sperm DNA for 4 hours at 42 °C. Hybridization was carried out overnight in the same buffer containing 10% dextran sulfate and 0.5 X10 6 cpm/ml 32 P-labelled full-length cDNA to human CRABP-II (specific activity > 10 8 cpm//ig). The filter was washed twice for 10 min in 2xSSC/0.1% SDS at room temperature, then twice for 20 min in 0.1 xSSC/0.1% SDS at 56°C. For normalization to human glycerol 3-phosphate dehydrogenase gene (G3PDH) expression, the filter was stripped of the radioactive CRABP-II probe by washing for 5 min in 0.1 % SDS at 95 °C. The blot was then re-probed with 32 P-labelled G3PDH probe (Clontech) as detailed above.
RT-PCR
A 1:2 serial dilution of target total RNA (from 64 ng down to 0.5 ng), together with 0.2 attomole of CRABP-D2 RNA, was mixed with nuclease-free water to a final volume of 7 /d, heated at 65°C for 5 min and then chilled on ice. Aliquoted RT mixture was added into the individual tubes to bring the final volume to 20 /il. Unless otherwise specified, each reaction contained 0.25 /iM human CRABP-II specific 3' primer CRB-2, 0.5 mM dNTP, 1 unit RNasin (Promega), 10 mM dithiothreitol (DTT), 1 xRT buffer (BRL, 50 mM Tris-HCl, pH 8.3, 75 mM KC1 and 3 mM MgCl 2 ), and 10 units of M-MLV reverse transcriptase (BRL). The reaction was incubated at 37°C for 1 hour, heated at 90°C for 4 min and then chilled on ice. 48 /il of the PCR master mixture containing 0.4 jtM CRB-1 and CRB-2 primers, 50 yM dNTP, 1 xPCR buffer (10 mM Tris-HCl, pH 8.3, 50 mM KC1, 2.5 mM MgCl 2 , 0.01% gelatin) and 2.5 units of Taq polymerase (Perkin Elmer Cetus) was added to a 2 /il aliquot of each RT reaction (one tenth of RT reaction). The mixture was overlaid with 40 id of mineral oil and amplified in a Thermal-Cycler (Perkin Elmer Cetus) for a total of 30 cycles. The first two cycles consisted of a denaturation step at 94°C for 2 minutes, an annealing step at 62 °C for 2 minutes and an elongation step at 72 °C for 5 minutes. The duration of the denaturation, the annealing and the elongation steps was each 1 minutes for the remaining 28 cycles.
Quantitative analysis 10 ^1 of PCR product was loaded onto an 8% nondenaturing polyacrylamide gel and subjected to electrophoresis. After staining with ethidium bromide (0.5 /xg/ml) for 20 min, the gel was photographed with Type 55 positive/negative film (Polaroid). The amplified DNA bands were quantitated using the computerized Bio Image analyzer system (Millipore). The ratio of the integrated optical density (IOD) obtained from the target and internal standard DNA bands was plotted out on a log-log scale against the amount of total RNA present in the RT reaction. The amount of human CRABP-II RNA was calculated from the plot. For Northern analysis, autoradiograms were quantitated on the Bio Image analyzer and the intensities were normalized to the density of G3PDH bands on the re-probed blot.
RESULTS
The internal standard CRABP-D2 RNA transcribed by T3 polymerase in vitro is structurally identical to the wild-type human CRABP-II RNA in the coding sequence except for a 42 bp deletion (equivalent to 16.4% of the target sequence encompassed by the PCR primers). The expected size of DNA amplified by PCR using the primers CRB-1 and CRB-2 is 214 bp for the Nucleic Acids Research, 1992, Vol. 20, No. 23 6217 CRABP-D2 RNA and 256 bp for the wild-type human CRABP-II RNA. The 42 bp difference in length allows these two bands to be easily separated on a polyacrylamide gel. Using 2 jtg of linearized CRABP-D2 DNA as template for transcription, about 20 ng of RNA was obtained. To eliminate the template DNA before the RNA was used as an internal standard for quantitative PCR, the in vitro transcribed product was digested with RNasefree DNase. It was also necessary to stringently purify the DNAfree RNA fragment by gel electrophoresis, since a false positive signal would result from even a trace amount of contaminating DNA template. The absence of DNA template from the internal RNA standard was tested by performing 40 cycles of PCR in the absence of RT; no evidence of DNA contamination was seen (data not shown). Total RNA, purified from cultured human skin fibroblasts treated with vehicle alone (ethanol) or containing retinoic acid (10~6 M), was serially diluted and subjected to RT-PCR together with a fixed concentration of internal standard CRABP-D2 RNA (0.2 attomole). Two DNA bands of 256 bp and 214 bp were observed after polyacrylamide gel electrophoresis (Fig. 1A) , consistent with the predicted sizes of target and internal standard CRABP-II RT-PCR products, respectively. To confirm the identity of the 256 bp DNA band, this fragment was gelpurified, then digested with two restriction enzymes, Pst I and Xcm I. The expected digestion patterns were observed (data not shown) suggesting that the 256 bp band amplified by PCR using primers CRB-1 and CRB-2 was indeed part of the human CRABP-n cDNA sequence and not the highly-related CRABP-I. Sequencing of the fragment confirmed this interpretation (data not shown).
In vehicle-treated cells, the intensity of the two bands was almost identical in lane 5 (Fig. 1A) . Since the same primers were used to amplify both standard and test RNAs, the efficiency of the amplification reaction should not differ for the two, assuming no effect of the small deletion in the standard cDNA (discussed below). It can be concluded, therefore, that in lane 5, the ratio of the target DNA to the internal standard DNA present in the original reaction mixture must have been 1:1, termed the 'equivalence point'. Because a known amount of internal standard RNA was used, the amount of CRABP-H RNA prior to RT-PCR can be determined. Thus, in lane 5, the amount of CRABP-II RNA in 0.8 ng of target RNA was almost equal to the amount of added internal standard CRABP-D2 RNA (0.02 attomole).
More accurate quantitation was achieved with the aid of a computerized image analyzer. First, the ratio of target to internal standard DNA band densities after RT-PCR was computed for each serial dilution. This ratio was then plotted against the amount of target RNA in each reaction. Consistent with the quantitative nature of the assay, the plotted relationship was linear on a loglog scale over at least a 100-fold range (Fig. IB) . The exact equivalence point could thus be obtained by interpolation, yielding a quantity of 24 attomole of CRABP-II RNA per microgram total RNA in fibroblasts treated with vehicle alone (Fig. 1C) .
Similar analysis was carried out on the RNA isolated from fibroblasts treated for 24 hours with 10~6 M RA. The equivalence point was shifted to lane 3, in which 0.2 ng of total RNA was initially used for the reaction (Fig. 1A) . The amount of CRABP-n in the RA-treated sample, therefore, was about 0.02 attomole per 0.2 ng of total RNA. Using the computer-assisted method detailed above, the level of CRABP-H RNA in RAinduced cells was calculated as 100 attomole/jtg, a 4.2-fold RNA "ANOVA showed a significant difference in RA versus vehicle treated skin (p<0.001). The blot was hybridized with 32 P-random primed human CRABP-II cDNA and the positive bands were quantitated by Bio Image system. The IOD was normalized to the density of the control G3PDH band and the induction of CRABP-n RNA was calculated.
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induction relative to the vehicle-treated cells (Fig. IB, 1C) . The quantitation of CRABP-II RNA was independently checked by serial dilution of the internal standard against a constant amount of fibroblast RNA and similar results were obtained (data not shown).
The induction of CRABP-II RNA in RA-induced human skin fibroblasts was consistent with results obtained by Northern blot analysis. The same RNA preparations were used for both quantitative PCR and the Northern blot. After hybridizing with the radiolabeled human CRABP-II cDNA probe, specific hybridizing bands were present with a size of approximately 1.3 kb (Fig. 2) . To standardize the results, the same blot was hybridized with a radiolabeled probe for G3PDH RNA, whose expression is unaffected by RA treatment (12) . The CRABP-II hybridizing bands were quantitated by image analysis of the autoradiogram and normalized to the density of the control G3PDH-hybridizing band. About 4.4-fold induction of CRABP-II RNA was calculated (Fig. 2) , in good agreement with results of quantitative PCR.
The primary goal in developing this technique was the quantitation of RNA from samples available only in limited quantity, such as liver, kidney or skin punch biopsies. To demonstrate that the method can be adapted for those clinical applications, human skin biopsies were used for the quantitation of CRABP-II RNA. Three subjects were treated topically with 0.1% RA cream, 2% SLS cream, or control treatments for 16 hours (for experimental details see Ref. 11 ) and the RNA isolated from human keratome biopsies (a gift from Dr. J.T. Elder, University of Michigan) was used for the quantitation. The protocol used was identical to that described above for cultured skin fibroblast RNA and the results from the three subjects are shown in Table 1 . The amount of CRABP-II RNA in biopsies from the subjects ranged from 15 to 25 attomole//tg total RNA, similar to the results from cultured human skin fibroblast cells (Fig. 1) . Treatment with both vehicle and SLS, a nonspecific irritant, caused a slight increase in CRABP-II RNA levels. In contrast, the induction of CRABP-II RNA after RA application was 12-fold over vehicle treatment in subject 1; 6.3-fold in subject 2 and 3.9-fold in subject 3.
DISCUSSION
Several factors were considered in designing the primers for PCR. First, CRB-1 and CRB-2 primers were designed to hybridize to the sequences located in different exons of human CRABP-II gene. The locations were based on the structure of the mouse CRABP-II gene (21) since no information on human CRABP-H genomic DNA was available. These two primers were tested using human genomic DNA as a template for PCR, and no DNA fragment could be observed after 35 cycles of amplification (data not shown). The amino acid sequence comparison of human CRABP-I and CRABP-n reveals 73% overall identity. To avoid the possible nonspecific amplification of CRABP-I cDNA, the primers were designed from the regions where the two genes showed the most divergent sequences. The specificity of the primers was confirmed by sequencing the amplified DNA band after RT-PCR (data not shown).
The deletion in the CRABP-n internal standard was designed to balance two opposing principles. Larger deletions increase the ease of separation of the internal standard DNA band from the target DNA band; however, a large difference in the DNA length may lead to a significant difference in the efficiency of PCR amplification. The internal standards that Gilliland and Wang (16, Nucleic Acids Research, 1992, Vol. 20, No. 23 6219 22) used, were 100 bp longer or 112 bp shorter than the target sequences (33% and 26% difference in DNA length, respectively) and there was no significant difference in the amplification efficiency. The internal standard we used here was only 16.4% shorter than the target sequence and should have no effect on the amplification efficiency. This assumption was tested by amplifying equal amounts of CRABP-II and CRABP-D2 DNA in one tube for 30 cycles. No significant difference was found in the amplification efficiency after scanning of the DNA bands (data not shown).
Using this method, the quantitation of CRABP-II RNA showed a linear relationship of band density ratio to input RNA over a 100-fold range. This dynamic range far exceeds the response to RA found by Northern blot analysis or quantitative PCR, thus ensuring the quantitative measurement of CRABP-II RNA levels over the naturally-occurring range found in this study. Astrom et. al. (11) have used Northern blot analysis to measure the expression of CRABP-II in human dermal fibroblasts and human skin. In human dermal fibroblasts treated with the same concentration of RA, the induction of CRABP-II RNA was 15-fold compared with 4.2-fold in our study. The difference in the induction may be due to the different cell line in this work. It is also possible that differences in passage number or degree of confluence may affect CRABP-II induction. In the previous work, CRABP-II transcripts were induced about 16-fold in RA treated relative to untreated human skin (11) . Our data showed a similar 10-fold induction compared to untreated skin; however, a smaller 7.4-fold increase was calculated relative to cream vehicle-treated skin.
An ideal method for quantitative PCR should be sensitive, accurate, rapid and widely applicable. Our procedure satisfies all of these criteria:
1. Sensitivity. The amount of RNA required for Northern blot analysis is usually 10 ng to 40 y.g, much greater than required for the quantitative PCR procedure (0.13 /tg). Considering only one tenth of the RT reaction was used for PCR amplification in our protocol, the actual amount of total RNA required could be further scaled down. The signal after quantitative PCR could be visualized by simple ethidium bromide staining even when the initial reaction mixture contained as little as 0.05 ng total RNA (Fig. 1A) . 0.02 attomole of internal standard could be routinely detected after the RT-PCR amplification, while in some cases we were able to detect the signal from as little as 0.005 attomole of internal standard RNA (data not shown).
Accuracy.
We have chosen a PCR method based on competitive amplification of target and internal standard cDNAs. Gilliland et. al. (16) developed a similar approach to quantitate cytokine mRNA from cultured cells. We have used a synthetic RNA, rather than DNA, as the internal standard. This modification allows the efficiency of all steps to be monitored throughout the RT-PCR reaction. Wang et. al. (22) also used a synthetic RNA as the internal standard to quantitate the mRNA levels of several lymphokines from cultured cells. However, in their method, the internal standard and target sequence do not co-amplify with identical efficiencies beyond 22 cycles due to different design and protocols. As a result the amplification in their system is cycle-dependent, limiting the amount of DNA they could obtain after PCR amplification. To boost sensitivity, 32 Plabelled primers were required in their experiments for the quantitation. In the method developed by our group and others, target and standard DNA co-amplify with identical efficiencies during the whole process of amplification (16) . The PCR is cycleindependent, permitting amplification to high copy number and visualization on ethidium bromide-stained gels (23) . Further advantages in convenience and safety are also realized for clinical use by obviating the need for radioisotopes.
Since a known internal standard RNA was used for quantitation, the quantitative PCR method described here allows calculation of the absolute number of molecules of CRABP-II RNA per microgram of total RNA. This calculation is not possible with Northern blot analysis, which allows only a relative quantitation such as fold induction. Our results have revealed that the amount of CRABP-II present in human keratome biopsies ranges from 16-25 attomole per microgram of total RNA. Further calculations can yield the number of CRABP-II RNA molecules on a per cell basis. For example, the untreated skin biopsy of subject 2 contains 16 attomole of CRABP-II RNA per microgram of total RNA. Typically, 1 /tg of total RNA represents the amount recovered from about 500,000 cells (24) . Using Avogadro's number for calculation, each cell contains an average of 20 molecules of CRABP-II RNA. Similarly, the level CRABP-II RNA is increased to about 200 molecules per cell after 16 hours of RA treatment.
3. Rapidity. The total process time for the quantitative-PCR described here is less than 8 hours excluding the time required for preparation of the internal standard RNA. Northern blot analysis, on the other hand, requires at least 2-3 days plus exposure time of up to one week. The method permits rapid quantitation of a large number of RNA samples. Compared to quantitative PCR methods developed by other groups (14, 15, 22) , the process time is also significantly shorter due to the simplicity of the protocol.
4. General applicability. Finally, this method can be applied to quantitation of RNA levels for virtually any gene whose cDNA has been cloned. Many clinically relevant genes are expressed in a tissue-specific manner, and may not be assayed from body fluids or blood. Tissue samples are necessarily small, and may be needed for other biochemical tests as well. Therefore, the ability to quantitatively measure gene expression from very limited amounts of solid tissue should be of great use in clinical, pharmacological and basic research.
